A revolution in weight loss treatment may soon be on the way — and it doesn’t involve a needle. Eli Lilly, the pharmaceutical ...

Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.

That’s why we have compiled a list of the best Ozempic alternatives available on the market. Our team has researched and tested each product thoroughly to bring you the most effective options.

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

This article lists Ozempic alternatives, including options for people with type 2 diabetes and obesity. Keep in mind that although some of the alternatives may not have an indication for weight ...

Ozempic made headlines. Now its maker faces stock crashes, CEO fallout, and fierce rivalry from Eli Lilly. Discover the trade behind the drama.

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

"The changes are made in light of the recent market challenges Novo Nordisk has been facing, and the development of the ...

Novo Nordisk has ousted chief executive Lars Fruergaard Jørgensen as the maker of pioneering obesity drug Ozempic battles a slump in profit growth, declining market share and a plunging stock price.

potentially replacing weight loss drugs like Ozempic with a natural alternative.

Novo Nordisk, the company that makes Wegovy and Ozempic, is abruptly ousting its chief executive over concerns the firm is ...

Novo Nordisk looks to harness Septerna’s broader GPCR drug pathways, which include GLP-1, for obesity and diabetes treatments ...